(18)FDG-PET/CT findings in COVID-19: a single centre retrospective radiological review

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes the infectious disease COVID-19, was declared a global pandemic in March 2020. As radiology departments recommence (18)FDG-PET/CT imaging, it is likely that both asymptomatic and specific symptomatic patients with COVID-1...

Descripción completa

Detalles Bibliográficos
Autores principales: Charters, Pia F. P., Little, David, Rodrigues, Jonathan C. L., Graham, Richard N, Redman, Stewart L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The British Institute of Radiology. 2020
Materias:
Case Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465739/
https://www.ncbi.nlm.nih.gov/pubmed/32922856
http://dx.doi.org/10.1259/bjrcr.20200091
Descripción
Sumario:The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes the infectious disease COVID-19, was declared a global pandemic in March 2020. As radiology departments recommence (18)FDG-PET/CT imaging, it is likely that both asymptomatic and specific symptomatic patients with COVID-19 infection will be imaged, particularly if the disease becomes endemic in the UK. We review the clinical scenarios where (18)FDG-PET/CT could be performed in COVID-19 positive patients. Our local protocol for safely scanning known COVID-19 positive patients is described, highlighting considerations for other departments. We present the findings from a series of known COVID-19 positive patients and two further asymptomatic cases evaluated with(18)FDG-PET/CT. Classic, indeterminate, normal and non-COVID-19 manifestations on both the (18)FDG-PETand low dose CT component are described as an aid for radiologists and nuclear medicine physicians when reporting (18)FDG PET/CT.

Ejemplares similares